Factors that affect the onset of action of non-depolarizing neuromuscular blocking agents [PDF]
Korean Journal of Anesthesiology, 2017 Neuromuscular blockade plays an important role in the safe management of patient airways, surgical field improvement, and respiratory care. Rapid-sequence induction of anesthesia is indispensable to emergency surgery and obstetric anesthesia, and its ...
Yong Byum Kim +2 more
doaj +3 more sources
Use of Neuromuscular Blocking Agents in Elderly Patients: A Narrative Review in Geriatric Medicine [PDF]
International Journal of General MedicinePaweł Radkowski,1– 3 Maciej Szewczyk,4 Tariq Dabdoub,1 Rubie Murthy,1 Łukasz Grabarczyk5 1Department of Anesthesiology and Intensive Care, Faculty of Medicine, Collegium Medicum University of Warmia and Mazury, Olsztyn, Poland ...
Radkowski P +4 more
doaj +2 more sources
Erratum: Factors that affect the onset of action of non-depolarizing neuromuscular blocking agents [PDF]
Korean Journal of Anesthesiology, 2017 [This corrects the article on p. 500 in vol. 70, PMID: 29046769.].
Yong Beom Kim +2 more
doaj +3 more sources
Intermediate acting non-depolarizing neuromuscular blocking agents and risk of postoperative respiratory complications: prospective propensity score matched cohort study [PDF]
BMJ, 2012 Objective: To determine whether use of intermediate acting neuromuscular blocking agents during general anesthesia increases the incidence of postoperative respiratory complications. Design: Prospective, propensity score matched cohort study.
Bateman, Brian Thomas +9 more
core +6 more sources
Prolonged neuromuscular blockade by non-depolarizing neuromuscular blocking agents [PDF]
JA Clinical Reports, 2019 Michiko Higashi +2 more
doaj +3 more sources
Sugammadex administration in patients with end-stage renal disease: a narrative review with recommendations [PDF]
Anesthesia and Pain Medicine, 2023 Due to unknown safety concerns, sugammadex should not be administered to patients with end-stage renal disease (ESRD). However, because the supply of benzylisoquinolinium-type neuromuscular blocking agents (NMBAs) has been discontinued, rocuronium is the
Seok Kyeong Oh, Byung Gun Lim
doaj +1 more source
Sugammadex: clinical development and practical use [PDF]
Korean Journal of Anesthesiology, 2013 Sugammadex is belonging to a new class of drugs: the selective relaxant binding agents. Sugammadex can reverse residual paralysis by encapsulating free circulating non depolarizing muscle relaxants.
Thomas Fuchs-Buder +2 more
doaj +1 more source
Current clinical application of dantrolene sodium [PDF]
Anesthesia and Pain Medicine, 2023 Dantrolene sodium (DS) was first introduced as an oral antispasmodic drug. However, in 1975, DS was demonstrated to be effective for managing malignant hyperthermia (MH) and was adopted as the primary therapeutic drug after intravenous administration ...
Hong Seuk Yang +5 more
doaj +1 more source
Resistance to non-depolarizing neuromuscular blocking agents
Asian Pacific Journal of Health Sciences, 2020 The authors experienced three cases of the resistance to the nondepolarizing neuromuscular blocking agents (NMBAs), rocuronium. There are many factors that affect NMBAs such as steroid, endocrine or autoimmune diseases which are thyroid disease, parathyroid disease, myasthenia gravis and etc., and anticonvulsant medication.
Dong-Min Hyun +4 more
openaire +1 more source
Comparison of the neuromuscular effects of two infusion rates of rocuronium in anesthetized pigs
Acta Veterinaria Scandinavica, 2022 Background: Neuromuscular blocking agents are frequently administered to pigs used for research. In humans, administration of the drugs is not without risk and may result in accidental awareness under general anaesthesia and postoperative residual ...
Kamilla Pedersen +3 more
doaj +1 more source